Literature DB >> 16965815

Different neutralization efficiency of neutralizing monoclonal antibodies against avian influenza H5N1 virus to virus strains from different hosts.

Hongliang Huang1, Hanbing Dan, Yanjun Zhou, Zhengjun Yu, Huiying Fan, Tiezhu Tong, Meilin Jin, Huanchun Chen.   

Abstract

BALB/c mice were immunized with formalin-treated influenza A/CK/Hubei/327/2004 virus. Six monoclonal antibodies specific to HA were selected, designed 1H8, 1D11, 2B7, 2C9, 2H4 and 4C9, respectively. The six Mabs probed linear epitopes by western blot assays. In ELISA additivity assays, the low additivity indexes (< or =28.3) of each pair Mabs indicated that the epitopes recognized by the six Mabs were located on the globular head of HA1. The neutralization activity of anti-HA1 Mabs and chicken polyclonal sera to various AIV H5N1 strains from different hosts was followed by virus neutralization with MDCK cells. All Mabs except 2C9 and chicken polyclonal serum showed highest neutralizing activity to lowly virulent A/Duck/XF/XFY/2004 from different phylogenetic lineage, and lowest neutralization efficiency to highly virulent A/CK/XF/XFJ/2004. For the other two highly virulent viruses, 1D11, 2H4, 4C9 and chicken polyclonal sera had higher neutralization to A/Goose/ZF/ZFE/2004 than A/CK/Hubei/327/2004, and 1H8 and 2B7 had considerable level of neutralizing efficiency to them. These findings suggested that the neutralizing antibodies showed lower neutralization efficiency to highly virulent virus strains than lowly virulent virus strains and strong cross-neutralizing reaction between virus strains located in different phylogenetic lineages. Moreover, the neutralizing Mabs could more efficiently neutralize AIV H5N1 strains from the natural hosts generally, such as waterfowl.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965815     DOI: 10.1016/j.molimm.2005.07.031

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses.

Authors:  Hsueh-Ling Janice Oh; Sara Akerström; Shuo Shen; Sándor Bereczky; Helen Karlberg; Jonas Klingström; Sunil K Lal; Ali Mirazimi; Yee-Joo Tan
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

2.  Antigenic characterization of recombinant hemagglutinin proteins derived from different avian influenza virus subtypes.

Authors:  Matthias Mueller; Sandra Renzullo; Roxann Brooks; Nicolas Ruggli; Martin A Hofmann
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

3.  Generation and characterisation of monoclonal antibodies against influenza virus A, subtype H5N1.

Authors:  Sonja Linke; Katrin Neubauer; Martin B Dorner; Brigitte G Dorner; Georg Pauli; Brunhilde Schweiger
Journal:  J Virol Methods       Date:  2011-04-28       Impact factor: 2.014

4.  Development of an Immunochromatographic Strip for Rapid Detection of Canine Adenovirus.

Authors:  Shujie Wang; Yongjun Wen; Tongqing An; Guixin Duan; MingXia Sun; Jinying Ge; Xi Li; Kongbin Yang; Xuehui Cai
Journal:  Front Microbiol       Date:  2019-12-11       Impact factor: 5.640

5.  Avian influenza (H5N1) virus in waterfowl and chickens, central China.

Authors:  Zhengjun Yu; Yunfeng Song; Hongbo Zhou; Xiaojuan Xu; Qiaoyun Hu; Haiya Wu; Anding Zhang; Yanjun Zhou; Jianfeng Chen; Hanbing Dan; Qingping Luo; Xiangmin Li; Huanchun Chen; Meilin Jin
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

6.  The antigenic property of the H5N1 avian influenza viruses isolated in central China.

Authors:  Wei Zou; Jianjiang Ke; Jiping Zhu; Hongbo Zhou; Meilin Jin
Journal:  Virol J       Date:  2012-08-06       Impact factor: 4.099

7.  Development of a blocking ELISA for detection of serum neutralizing antibodies against newly emerged duck Tembusu virus.

Authors:  Xuesong Li; Guoxin Li; Qiaoyang Teng; Lei Yu; Xiaogang Wu; Zejun Li
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.